Pacer BioThreat Strategy 

$39.96
3
-$0.05-0.14% Thursday 19:49

Statistics

Day High
40.03
Day Low
40
52W High
40.03
52W Low
29.24
Volume
1,985
Avg. Volume
391
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.2%
Dividend
0.08

Upcoming

Dividends

0.2%Dividend Yield
Mar 26
$0.08
Jan 26
$0.08
Oct 25
$0.07
Jul 25
$0.1
Mar 25
$0.08
10Y Growth
N/A
5Y Growth
7.33%
3Y Growth
2.03%
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VIRS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, includes biotech companies that could overlap with VIRS's investments in biothreat prevention and treatment.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, offers broad exposure to the biotech sector, including companies that may work on biothreat solutions.
iShares Biotechnology
IBB
Mkt Cap0
iShares Biotechnology ETF, covers biotech firms that could be involved in developing treatments or vaccines for biothreats.
Principal Healthcare Innovators
BTEC
Mkt Cap0
Principal Healthcare Innovators Index ETF, focuses on early-stage healthcare innovation, potentially including biothreat mitigation technologies.
iShares Genomics Immunology and Healthcare
IDNA
Mkt Cap0
iShares Genomics Immunology and Healthcare ETF, invests in companies that could be at the forefront of addressing biothreats through advanced medical research.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund, includes biotech companies that may engage in biothreat response efforts.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF, targets biotech and genome companies, some of which may focus on biothreats.
Global X Genomics & Biotechnology
GNOM
Mkt Cap0
Global X Genomics & Biotechnology ETF, focuses on genomics and biotech, sectors crucial for developing biothreat countermeasures.
ARK Genomic Revolution
ARKG
Mkt Cap0
ARK Genomic Revolution ETF, invests in companies across genomics, including those potentially involved in combating biothreats.

About

Miscellaneous
Investment Trusts/Mutual Funds
The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. The Advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. It is non-diversified.
Show more...
CEO
Country
US
ISIN
US69374H7585

Listings

0 Comments

Share your thoughts

FAQ

What is Pacer BioThreat Strategy stock price today?
The current price of VIRS is $39.96 USD — it has decreased by -0.14% in the past 24 hours. Watch Pacer BioThreat Strategy stock price performance more closely on the chart.
What is Pacer BioThreat Strategy stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pacer BioThreat Strategy stocks are traded under the ticker VIRS.
Does Pacer BioThreat Strategy pay dividends?
Yes, VIRS dividends are paid quarterly. The last dividend per share was 0.08 USD. As of today, Dividend Yield (FWD)% is 0.2%.
In which sector is Pacer BioThreat Strategy located?
Pacer BioThreat Strategy operates in the Other sector.
When did Pacer BioThreat Strategy complete a stock split?
Pacer BioThreat Strategy has not had any recent stock splits.